Earnings Call Insights: Krystal Biotech (KRYS) Q3 2025 Management View CEO Krish Krishnan opened the call highlighting the continued momentum in the VYJUVEK launch. He stated, “In Q3, VYJUVEK launch continued to build momentum and the updated U.S. label clearly strengthens long-term outlook in the U.S. We’re now launched in Germany, France and Japa…
START SELLING WITH BigBCC TODAY
Start your free trial with BigBCC today.
BLOG | Global Expansion
Krystal Biotech targets global expansion for VYJUVEK with launches in Germany, France, and Japan amid pipeline acceleration






